Texas A&M University
College Station, Texas, 77843, United States
NCT Number: NCT07631546
This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent hypertension. The main questions it aims to answer are:
1. Does digital mobile health coaching impact hypertension management outcomes, including blood pressure and adherence? 2. How does adherence to mobile health intervention influence the long-term man-agement and outcomes of hypertension? 3. How are health beliefs and QOL affected by digital coaching and health tracking for hypertension management?
Participants will be required to complete the following:
Blood pressure reading every day Weight reading every day Take hypertension medication as prescribed by their physician Complete educational content (if on coaching group) Belief and Attitudes Survey (before and after study) Personality Assessment Survey Demographic Information Survey Hypertension Health Literacy Survey (before and after study) Two General Health Literacy Surveys (before and after study) Quality of Life Survey
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Interventional
Not applicable
College Station, Texas, 77843, United States
Background: Hypertension has become one of the most common conditions in the world. Approximately 1.28 billion people suffer from this ailment. Change is required in the world of today to adopt more health-conscious practices to avoid further growth of the population suffering from this affliction.
Objective: This project aims to promote general wellness using a mobile health intervention that incorporates health coaching to help manage hypertension. The mobile application (HyperCoach) does not intend to cure, mitigate, or prevent hypertension.
Health coaching is a method designed to guide participants in attaining their health goals through active intervention providing them with educational content, reminders, goal-setting capabilities, and feedback. The educational content will be conducted by introducing the participant to the process of performing their body measurements properly (blood pressure and weight) and then through training through our designed phone application. Reminders will be sent if the participant has yet to complete their assigned tasks of the day.
At the beginning of the study, participants will have the opportunity to establish their own personal health goals for blood pressure, resting heart rate, weight, and step count in HyperCoach. At the end of every week, participants will have the opportunity to have a progress report available to them to demonstrate their current trends regarding their weight, blood pressure, resting heart rate, and step count. The progress report will also allow users to change their current goals for more appropriate ones according to their health and knowledge development.
The 40 participants will be provided with a Bluetooth-enabled blood pressure cuff and weight scale. The devices will be used alongside the participants' IOS phones to collect their blood pressure and weight readings through the use of the iPhone Application - HyperCoach. The application will provide the participants with American Heart Association (AHA) approved content in the form of flyers, messages, and videos. The application automatically saves the measurements of the participant as long as the application is open and Bluetooth is functional. The app will look at the readings of the participants and assess their status (green, yellow, orange, red) based on the algorithm provided by the AHA and provide a visual representation of the participant's health trends.
References: All coaching content has been designed or selected with the input of one of our sponsors, the American Heart Association. Content that will be provided may be found on the American Heart Association website, Pennington Biomedical Research Center website(under Pennington Nutrition Series), and Harvard Health Publishing website. Also, some videos that will be shown to the participants may be found under the following Youtube Channels: American Heart Association, Sanitas, British Heart Foundation, and SabiasMass. These Youtube Channels cover relevant health coaching information that has been reviewed for inclusion.
Questionnaires: All questionnaires will be performed through Qualtrics, except for the consent form, which will be signed through DocuSign.
HyperCoach: The application will send daily reminders through phone notifications through the HyperCoach app to complete their measurement (weight and blood pressure), review educational material, and complete their knowledge assessments. The application only permits participants to track their health measurements and access educational content to improve their health. It is not providing any treatment options to the participant regarding their condition. The purpose is to allow them to know their current medical measurements (weight & blood pressure) and provide health coaching to advise them on improving their health.
Data Collection: Information about the participant will be stored in a locked file cabinet. Computer files are protected with a password. Participant contact information will be deleted after successful completion of this study.
The clinical outcomes of the study are the following:
To differentiate between the two participant groups:
The non-coaching group will only have access to the daily reminders and trend graphs for the duration of the study.
Group Assignment:
The participants will be assigned to their group according to the order they sign-up for the study. Every third person who registers for the study will be in the non-coaching group, and all others in the coaching group.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participants will have the opportunity to establish their own personal health goals for blood pressure, resting heart rate, weight, and step count in HyperCoach. At the end of every week, participants will have the opportunity to have a progress report available to them to demonstrate their current trends regarding their weight, blood pressure, resting heart rate, and step count. The progress report will also allow users to change their current goals to more appropriate ones according to their health and knowledge development. The participants will be provided with a Bluetooth-enabled blood pressure cuff and weight scale. The devices will be used alongside the participants' IOS phones to collect their blood pressure and weight readings through the use of the iPhone Application - HyperCoach. The application will provide the participants with American Heart Association (AHA) approved content in the form of flyers, messages, and videos.
Other names: HyperCoach
Daily reminders to monitor bloodp pressure and weight , mobile platform functions are disabled except for biofeedback and trend graphs.
Time frame: From enrollment to Day 90 and 270 of the intervention.
Blood pressure was measured by participants using a blood pressure cuff.
Time frame: From enrollment to the end of the treatment at Day 90 and 270.
Blood pressure was measured by the participants using blood pressure cuffs.
Time frame: From enrollment to the end of treatment at 90 days and 270 days.
Total change in body weight in pounds measured with a weight scale.
Time frame: Surveys will be completed on enrollment, day 90, and day 270 of the study.
Participants will complete the Quality of Life (SF-36) survey before beginning the Digital Coaching or Health Awareness intervention. The survey will be administered again at the 90-day and 270-day study time points. The SF-36 has a maximum score of 100, indicating that participants perceive themselves to be in excellent mental and physical health, whereas a minimum score of 0 indicates the poorest perceived health status.
Time frame: Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Participants will complete the Health Belief Analysis (composed of the following scores: Perceived Health Threat, Self-Efficacy, Perceived Barriers, and Cues to Action). All survey items are measured using a 7-point Likert scale ranging from 1 ("Strongly Disagree") to 7 ("Strongly Agree"). Higher scores indicate greater agreement with the construct being measured. For each individual subconstruct from each survey, higher scores represent higher levels of the corresponding construct.
Time frame: Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Participants will complete the Technology Acceptance Model (composed of the following scores: Attitude, Perceived Usefulness, and Perceived Ease of Use). All survey items are measured using a 7-point Likert scale ranging from 1 ("Strongly Disagree") to 7 ("Strongly Agree"). Higher scores indicate greater agreement with the construct being measured. For each individual subconstruct from each survey (i.e., perceived ease of use), higher scores represent higher levels of the corresponding construct. .
Time frame: Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Participants will complete the Dual Factor model (composed of the Resistance to Change score). All survey items are measured using a 7-point Likert scale ranging from 1 ("Strongly Disagree") to 7 ("Strongly Agree"). Higher scores indicate greater agreement with the construct being measured.
Time frame: Participant activities will be tracked from the day of enrollment through day 90, and subsequently through day 270.
Participants' adherence will be assessed based on the completion of morning and evening blood pressure measurements recorded within the HyperCoach application throughout the intervention period. Higher completion rates of scheduled blood pressure measurements will indicate greater adherence to the study protocol.
Time frame: Participant activities will be tracked from the day of enrollment through day 90, and subsequently through day 270.
Participants' adherence will be assessed based on the completion of their daily weight measurements recorded within the HyperCoach application throughout the intervention period. Higher completion rates of weight measurements will indicate greater adherence to the study protocol.
Time frame: Participant activities will be tracked from the day of enrollment through day 90.
For participants assigned to the Digital Coaching group, adherence will also be assessed based on the completion of assigned coaching tasks within the HyperCoach application throughout the intervention period. Higher completion rates of coaching tasks will indicate greater engagement and adherence to the Digital Coaching intervention.
Time frame: Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Participants will complete the Short Assessment of Health Literacy survey before beginning the intervention period. The survey consists of 18 items designed to assess participants' health literacy. Scores range from 0 to 18, with higher scores indicating greater health literacy and a better ability to understand and apply health-related information.
Time frame: Surveys will be completed at enrollment, on day 90, and on day 270 of the study.
Participants will complete a health literacy and health behavior survey composed of multiple sections assessing general and health condition literacy. The survey is composed of 61 questions: including 15 questions regarding health behaviors, 18 questions for General Health Literacy Assessment, 5 questions assessing Diabetes Literacy, 5 questions assessing High Blood Pressure Literacy, 5 questions assessing Cholesterol Literacy, 5 questions assessing Heart Failure Literacy, and 8 questions assessing Cardiometabolic Literacy. Higher scores indicate greater health literacy. Lower scores indicate more limited health literacy and understanding of chronic disease management.
Texas A&M University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05198674
Cardiovascular Diseases, Chronic Disease
Birmingham, Alabama, United States
View Trial DetailsNCT07727356
ACTH Syndrome, Ectopic, Adrenal Gland Diseases
Zurich, Switzerland
View Trial DetailsNCT06205628
Cardiovascular Diseases, Essential Hypertension
Adelaide, South Australia, Australia
View Trial DetailsNCT07726394
Cardiovascular Diseases, Hypernatremia
Subang Jaya, Selangor, Malaysia
View Trial Details